Saturday 17 October 2026
Export VEEV’s income statement to Excel — free account
Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
310.30
2.73
−0.87%
Follow VEEV
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
32.81 | 27.08 | 36.57 | 55.26 |
+8 more quarters Free account |
P/S ratio |
9.57 | 7.68 | 10.42 | 15.51 | |
P/FCF ratio |
20.19 | 15.53 | 24.01 | 35.36 | |
P/Operating CF |
138.59 | 22.60 | 311.49 | 247.79 | |
P/B ratio |
4.45 | 3.49 | 4.61 | 6.79 | |
Price to Tangible BV |
4.81 | 3.77 | 4.93 | 7.27 | |
EV/Sales |
7.47 | 5.47 | 8.36 | 13.35 | |
EV/EBITDA |
23.81 | 18.10 | 27.80 | 45.50 | |
EV/Operating CF |
15.52 | 10.91 | 18.88 | 29.85 | |
EV/FCF |
15.77 | 11.07 | 19.28 | 30.44 | |
Quick Ratio |
5.36 | 4.67 | 4.81 | 7.42 | |
Current Ratio |
5.46 | 4.74 | 4.89 | 7.53 | |
Net Debt/EBITDA |
(25.00) | (25.41) | (25.69) | (26.29) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.41 | 0.39 | 0.39 | 0.42 | |
Operating CF/Net income |
0.87 | 4.32 | 0.44 | 0.82 | |
Capex/Depreciation |
(0.54) | (0.12) | (0.74) | (0.85) | |
Research and Development Expense of Revenue |
24.02% | 23.59% | 23.78% | 23.65% | |
Selling, General and Administrative Expense of Revenue |
21.34% | 20.45% | 21.27% | 22.07% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.05 | 0.06 | |
Share Based Compensation of Revenue |
14.74% | 13.51% | 14.15% | 14.83% | |
Graham Net Nets |
0.19 | 0.24 | 0.19 | 0.13 | |
Graham Number |
79.98 | 76.13 | 74.26 | 71.34 | |
Earnings Yield |
3.05% | 3.69% | 2.73% | 1.81% | |
Free Cash Flow Yield |
4.95% | 6.44% | 4.16% | 2.83% | |
Revenue per Share |
5.72 | 5.41 | 5.11 | 4.95 | |
Operating CF per Share |
1.47 | 6.90 | 0.65 | 1.18 | |
Capex per Share |
(0.05) | (0.01) | (0.04) | (0.06) | |
Free Cash Flow per Share |
1.42 | 6.89 | 0.61 | 1.11 | |
Cash per Share |
44.61 | 44.77 | 40.09 | 40.46 | |
Shareholders Equity per Share |
45.78 | 44.72 | 44.08 | 42.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
45.78 | 44.72 | 44.08 | 42.92 | |
Free Cash Flow |
230.69 | 1,125.37 | 99.82 | 182.90 | |
Working Capital |
6,490.28 | 6,361.49 | 6,360.57 | 6,166.98 | |
Capital Expenditures |
(8.02) | (1.75) | (7.03) | (9.89) | |
Net Current Asset Value |
6,317.45 | 6,238.06 | 6,233.04 | 6,055.33 | |
EV/EBIT |
24.97 | 19.01 | 29.16 | 47.89 | |
Capex to Sales |
0.01 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
31.97 | 26.66 | 36.32 | 55.62 | |
| Other line items | |||||
Average Receivables |
519.03 | 584.53 | 1,183.73 | 336.53 | |
Average Payables |
34.78 | 39.04 | 34.05 | 32.26 | |
Average Assets |
8,529.83 | 8,447.32 | 8,159.55 | 7,275.00 | |
Average Common Equity |
7,034.99 | 6,757.73 | 6,523.56 | 6,271.02 |
Columns are period end dates